Company profile for DiaCarta

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

DiaCarta is Changing the Landscape of Precision Molecular Diagnostics DiaCarta, a translational genomics and precision molecular diagnostics company, was established in 2011 to provide highly sensitive and advanced technologies that will improve the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. With over 80 global patents, DiaCarta ...
DiaCarta is Changing the Landscape of Precision Molecular Diagnostics DiaCarta, a translational genomics and precision molecular diagnostics company, was established in 2011 to provide highly sensitive and advanced technologies that will improve the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. With over 80 global patents, DiaCarta offers a range of products and services, from single-gene cancer mutation detection qPCR assays, colorectal cancer mutation detection panels, radiation therapy toxicity monitoring cfDNA test to its targeted NGS panels.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2600 Hilltop Drive Richmond, CA 94806
Telephone
Telephone
1-800-246-8878
Linkedin
Linkedin
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/diacarta-and-capstone-health-alliance-collaborate-to-bring-revolutionary-diagnostic-tests-to-enhance-patient-care-302182660.html

PR NEWSWIRE
26 Jun 2024

https://www.prnewswire.com/news-releases/diacarta-inc-and-oncoassure-ltd-collaborate-to-launch-prostate-cancer-lab-developed-test-302070523.html

PR NEWSWIRE
26 Feb 2024

https://www.globenewswire.com/news-release/2023/05/09/2665104/0/en/DiaCarta-Receives-Accreditation-by-the-College-of-American-Pathologists-CAP.html

GLOBENEWSWIRE
09 May 2023

https://www.globenewswire.com/news-release/2023/01/12/2587880/0/en/DiaCarta-Receives-U-S-FDA-Emergency-Use-Authorization-for-its-Monkeypox-Test-Kit.html

GLOBENEWSWIRE
12 Jan 2023

https://www.globenewswire.com//news-release/2023/01/05/2583628/0/en/DiaCarta-Announces-Successful-Completion-of-Oncuria-Validation-Study-with-Nonagen-Bioscience.html

GLOBENEWSWIRE
05 Jan 2023

https://www.biospace.com/article/releases/diacarta-s-coloscape-assay-detects-precancerous-colorectal-cancer-lesions-and-colorectal-cancer-mutations-with-high-sensitivity/?s=71

BIOSPACE
27 Oct 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty